SSY Company Profile and Key Details

SunLink Health Systems, Inc. generated EPS of -$0.55 over the past year. Five-year average earnings growth is -13.18%.

SSY has shown sold momentum, gaining 3.7% over the past week and 30.23% over the past quarter, though year-to-date performance is up 27.27%. Short-term trend indicators are bearishly aligned (SMA20 3.67%, SMA50 16.78%, SMA200 30.65%). The stock’s 14-day RSI is 56.45 (neutral), while the ATR of 0.13 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -36.06% below its high and over 95.48% above its low.

SunLink Health Systems, Inc. has 7.04 million shares outstanding. The public float is 4.66 million shares, elevated short interest at 0.20% of float. This equals 10.60 thousand shares. The short ratio is 0.05 days. Institutional investors hold 20.43% of the float. Insiders own 28.36%. THORNTON ROBERT M JR holds 543.34 thousand shares, BAILEYS STEVEN J has 521.24 thousand shares and TURNER HOWARD E has 205.78 thousand shares.

SunLink Health Systems, Inc. (AMEX:SSY) closed at $1.11 USD, gaining $0.16 (16.15%) from the previous close of $0.96. The stock is currently mid-range between its 52-week high and low $0.62 and $1.91. With a market capitalization of about $7.85 million, SunLink Health Systems, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.15). Key stats such as the average daily volume over the past year has been around 194.38 thousand shares, in line with its 52-week average. Headquartered in Atlanta, GA, SunLink Health Systems, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Robert M. Thornton Jr., the company employs approximately 1,376 people and listed since March 18, 1980. SunLink Health Systems, Inc., established in 1959 and headquartered in Atlanta, Georgia, delivers an array of healthcare products and services across the southeastern United States.

SunLink Health Systems, Inc. last paid a dividend of 0.1 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.23. This means the shares are trading below this model’s fair value.

SunLink Health Systems, Inc. trades at a P/E ratio of -3.84, slightly below the S&P 500 average, with a price-to-sales ratio of 0.51 and a price-to-book ratio of 0.59 suggesting the stock is closer to book value. The P/FCF stands at -3.93, also above market averages.

Our AI price prediction model suggests that SunLink Health Systems, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -16.96%, with price expected at $0.93 by August 28, 2025, within a range of $0.83 to $1.02 3-Month Outlook: Projected rise of 6.25%, reaching $1.19 by November 12, 2025, with a range of $1.15 to $1.22. 1-Year Outlook: Projected gain of 1172.32%, with price at $14.25 by August 14, 2026, within a range of $10.10 to $19.34.

SunLink Health Systems, Inc. (AMEX:SSY) shares are up 27.27% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows SunLink Health Systems, Inc. trading at a premium to the broader market with a P/E of -3.84. Our AI forecast model points to short-term weakness (-16.96% over two weeks), a medium-term rise (6.25% over three months), and a longer-term gain (1172.32% over one year), with expected trading ranges indicating moderate volatility.